Suchergebnisse - "Mano, Yoko"

PubPharm (54)

1

Population Pharmacokinetics of Ozoralizumab in Patients with Rheumatoid Arthritis

enthalten in: Journal of clinical pharmacology | 2024

von Takeuchi, T. | Chino, Y. | Mano, Y. | +4

2

Population Pharmacokinetics of Ozoralizumab in Patients with Rheumatoid Arthritis

enthalten in: The Journal of Clinical Pharmacology | 2024

von Takeuchi, T. | Chino, Y. | Mano, Y. | +4

3

Pharmacokinetics, pharmacodynamics and safety profile of the dual orexin receptor antagonist vornorexant/TS-142 in healthy Japanese participants following single/multiple dosing : Randomized, double-blind, placebo-controlled phase-1 studies

enthalten in: Basic & clinical pharmacology & toxicology | 2023

von Kambe, D. | Hasegawa, S. | Imadera, Y. | +6

4

Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα NANOBODY® compound, in patients with rheumatoid arthritis : 52-week results from the OHZORA and NATSUZORA trials

enthalten in: Arthritis research & therapy | 2023

von Takeuchi, T. | Chino, Y. | Kawanishi, M. | +6

5

Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα $ NANOBODY^{®} $ compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials

enthalten in: Arthritis Research & Therapy | 2023

von Takeuchi, T. | Chino, Y. | Kawanishi, M. | +6

6

Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα $ NANOBODY^{®} $ compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials

enthalten in: Arthritis Research & Therapy | 2023

von Takeuchi, T. | Chino, Y. | Kawanishi, M. | +6

7

Pharmacokinetics, pharmacodynamics and safety profile of the dual orexin receptor antagonist vornorexant/TS‐142 in healthy Japanese participants following single/multiple dosing : Randomized, double‐blind, placebo‐controlled phase‐1 studies

enthalten in: Basic & Clinical Pharmacology & Toxicology | 2023

von Kambe, D. | Hasegawa, S. | Imadera, Y. | +6

8

The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non-small cell lung cancer

enthalten in: Thoracic cancer | 2022

von Shimizu, M. | Miyanaga, A. | Seike, M. | +8

9

The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non‐small cell lung cancer

enthalten in: Thoracic Cancer | 2022

von Shimizu, M. | Miyanaga, A. | Seike, M. | +8

10

Drug-drug interaction potential and clinical pharmacokinetics of enerisant, a novel potent and selective histamine H3 receptor antagonist

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2021

von Terasaka, S. | Hachiuma, K. | Mano, Y. | +4

1
2
3
4
5
6
Nächster »
[6]